Zevalin: 90yttrium labeled anti-CD20 (ibritumomab tiuxetan), a new treatment for non-Hodgkin's lymphoma (Q33340348)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Zevalin: 90yttrium labeled anti-CD20 (ibritumomab tiuxetan), a new treatment for non-Hodgkin's lymphoma |
scientific article |
Statements
1 reference
Zevalin: 90yttrium labeled anti-CD20 (ibritumomab tiuxetan), a new treatment for non-Hodgkin's lymphoma (English)
1 reference
C Krasner
1 reference
R M Joyce
1 reference
1 December 2001
1 reference
1 reference
341-349
1 reference
Identifiers
1 reference
1 reference